Skip to the page

Data / Medical devices / Israel / Inspiremd, Ltd.

Inspiremd, Ltd.: FDA-registered device maker in Tel Aviv, Israel, 1 PMA approval

Inspiremd, Ltd. is registered with the FDA (registration 3031658894) in Tel Aviv, Israel. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated June 23, 2025. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3031658894
Address
4 Menorat HaMaor Street, Tel Aviv, Israel, 6744832
Owner or operator
InspireMD, Ltd. (10093698)
Roles
Complaint file establishment, Manufacturer
First device listed
June 25, 2025
Registered through
2026
Brand names listed
CGuard Prime Carotid Stent System

Devices it lists

DeviceProduct codeClassRoleSource
Stent, CarotidNIM3Complaint file establishment, Manufactureraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
June 23, 2025P240029CGuard Prime Carotid Stent SystemNIM2March 16, 2026accessdata.fda.gov

Compare with other makers

Updated March 16, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.